All low density lipoprotein particles are partially desialylated in plasma

Atherosclerosis

Volumn 138, Issue 2, 1998, Pages 237-245

  Bartlett, Anna L ^a   Stanley, Keith K ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Atherosclerosis; Desialylation; Low density lipoprotein; Ricin

Indexed keywords

APOLIPOPROTEIN B; GALACTOSE; GLUCOSE; GLYCOSYLATED PROTEIN; LACTOSE; LOW DENSITY LIPOPROTEIN; MANNOSE; PLANT LECTIN; SIALIC ACID; SODIUM CHLORIDE; TRANSFERRIN;

ARTICLE; ATHEROGENESIS; HUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RICINUS COMMUNIS; SIALYLATION;

CASTOR BEAN; HUMANS; LECTINS; LIPOPROTEINS, LDL; PLANT LECTINS; PLANTS, TOXIC; RICIN; SIALIC ACIDS;

EID: 0032103202     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00288-8     Document Type: Article

References (41)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL Beyond cholesterol. Modifications of low density lipoproteins that increase its atherogenicity. New Engl J Med. 320:1989;915-924.
2. Geng YJ, Hanson GKJ Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. Clin Invest. 89:1992;1322-1330.
3. Ternov W, Sobenin IA, Gabbasov AA, Popov EG, Orekhov AN. Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. Biochem Biophys Res Commun. 163:1989;489-494.
4. Khoo JC, Miller E, McLaughlin P, Steinberg D Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Atherosclerosis. 8:1988;348-358.
5. Weisgraber KH, Innerarity TL, Mahley RW Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors in human fibroblast. J Biol Chem. 253:1978;9053-9062.
6. Orekhov AN, Tertov W, Mukhin DN, Mikhailenko IA Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells. Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem Biophys Res Commun. 162:1989;206-211.
7. Tertov W, Sobenin IA, Gabbasov ZA et al. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Lab Invest. 67:1992;665-675.
8. Orekhov AN, Tertov VV, Mukhin DN Desialylated low density lipoprotein - naturally occurring lipoprotein with atherogenic potency. Atherosclerosis. 86:1991;153-161.
9. Tertov W, Orekhov AN, Sobenin IA, Morrisett JD, Gotto AM, Guevara JG. Jr Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. J Lipid Res. 34:1993;365-375.
10. Ruelland A, Gallou G, Legras B, Paillard F, Cloarec L LDL sialic acid content in patients with coronary artery disease. Clin Chim Acta. 221:1993;127-133.
11. Orekhov AN, Terrtov W, Pokrosvsky SN Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low density lipoproteins and an approach to its elimination. Circ Res. 62:1988;421-429.
12. Terrtov W, Orekhov AN, Marrtsenyuk ON, Perova NV, Smirnov VN Low density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells. Exp Mol Pathol. 50:1989;337-347.
13. Avila EM, Lopez F, Camejo G. Properties of low density lipoprotein related to its interaction with aderial wall components: in vitro and vivo studies. Artery. 4:1978;36-60.
14. Filipovic I, Buddecke E. Role of net charge of low density lipoproteins in high affinity binding and uptake by cultured cells. Biochem Biophys Res Commun. 88:1979;485-490.
15. Malmandier C, Delcroix C, Fontaine M. Effect of sialic acid removal on human low density lipoprotein catabolism in vivo. Atherosclerosis. 37:1980;277-284.
16. Ii M, Kurata H, Itoh N, Yamashina I, Kawasaki T Molecular cloning and 1 sequence analysis of cDNA encoding the macrophage lectin specific for galactose and N-acetylgalactosamine. J Biol Chem. 265:1990;11295-11298.
17. Ozaki K, Ii M, Itoh N, Kawasaki T. Expression of a functional asialoglycoprotein receptor through transfection of a cloned cDNA that encodes a macrophage lectin. J Biol Chem. 267:1992;9229-9235.
18. Knott TJ, Pease RJ, Powell LM Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature. 323:1986;734-738.
19. Yang C-Y, Chen S-H, Gianturco SH Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Nature. 323:1986;738-742.
20. Taniguchi T, Ishikawa Y, Tsunemitsu M, Fukuzaki H. The structures of the asparagine-linked sugar chains of human apolipoprotein B-100. Arch Biochem Biophys. 273:1989;197.
21. Sattler W, Mohr D, Stocker R. Rapid isolation of HDL, LDL and VLDL and assessment of their peroxidation by HPLC post-column chemiluminescence detection. Methods Enzymol. 223:1994;469-489.
22. Chung BH, Segrest JP, Ray MJ, Brunzell JD, Hokason JE, Krauss RM, Beaudine K. Single vertical spin density gradient ultracentrifugation. Methods Enzymol. 128:1986;181-209.
23. Kritharides L, Jessup W, Gifford J, Dean RT. A method for defining the stages of low density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC. Anal Biochem. 213:1993;79-89.
24. Morton RE, Evans TA. Modification of the bicinchoninic acid protein assay to eliminate lipid interference in determining lipoprotein content. Anal Biochem. 204:1992;332.
25. Macquarie Research, Williams KL, Packer NH, Redmond JW, Gooley AA. Desalting and purification of oligosaccharides and their derivatives. Australian Provisional Patent No. PN6948 1996.
26. Camejo G, Lopez A, Quinones J. Interaction of low density lipoproteins with arterial proteoglycans: the role of charge and sialic acid content. Atherosclerosis. 55:1985;93-105.
27. Grewal T, Bartlett A, Burgess JW, Packer NH, Stanley KK. Desialylated LDL uptake in human and mouse macrophages can be mediated by lectin receptor. Atherosclerosis. 121:1996;151-163.
28. Green ED, Brodbeck RM, Baenziger JU. Lectin affinity high-performance liquid chromatography. Interactions of N-glycanase-released oligosaccharides with Ricinus communis agglutinin I and Ricinus communis agglutinin II. J Biol Chem. 262:1987;12030-12039.
29. Thompson GR. A Handbook of Hyperlipidaemia. 1989;Current Science, London. and references therein.
30. Rademacher TW, Parekh RB, Dwek RA. Glycobiology. Ann Rev Biochem. 57:1988;785-838.
31. McGuire JM, Douglas M, Smith KD. The resolution of neutral N-linked oligosaccharides of IgG by high pH anion-exchange chromatography. Carbohydr Res. 292:1996;1-9.
32. Deisenhoffer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry. 20:1981;2361-2370.
33. Wada Y, Nishikawa A, Okamoto N, Inui K, Tsukamoto H, Okada S, Taniguchi N. Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem Biophys Res Commun. 189:1992;832-836.
34. Sottrup-Jensen L, Stepanik TM, Kristensen T, Wierzbicki DM, Jones CM, Lonblad PB, Magnusson S, Petersen TE. Primary structure of human α2-macroglobulin. V. The complete structure. J. Biol Chem. 259:1984;8318-8327.
35. Hanaoka K, Pritchett TJ, Takasaki S, Kochbe N, Sabesan S, Paulson JC, Kobata A. 4-O-acetyl-N-acetylneuraminic acid in the N-linked carbohydrate structures of equine and guinea pig α2-macroglobulins, potent inhibitors of influenza virus infection. J Biol Chem. 264:1989;9842-9849.
36. Zannis VI, Breslow JL. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and post-translational modification. Biochemistry. 20:1981;1033-1041.
37. Wernette-Hammond ME, Lauer SJ, Corsini A, Walker D, Taylor JM, Stanley CR Jr Glycosylation of human apolipoprotein. J Biol Chem. 264:1989;9094-9101.
38. Lee YC, Townsend RR, Hardy MR, Longren J, Arnap J, Haraldsson M, Lonn H. Binding of synthetic oligosaccharides to hepatic Gal/GalNAc lectin. Dependence on fine structural features. J Biol Chem. 258:1983;199-202.
39. Ozaki K, Lee RT, Lee YC, Kawasaki T. The differences in structural specificity for recognition and binding between asialoglycoprotein receptors of liver and macrophages. Glycoconjugate J. 12:1995;268-274.
40. Snyder ML, Polacek D, Scanu AM, Fless GM. Comparative binding and degradation of lipoprotein (a) and low density lipoprotein by human monocytederived macrophages. J Biol Chem. 267:1992;339-346.
41. Lentner C, editor. Geigy Scientific Tables, Ciba-Geigy, Basle, Switzerland 1981, and references therein.